0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Amlodipine Besylate Tablets Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-38E9912
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global Amlodipine Besylate Tablets Market Insights Forecast to 2028
BUY CHAPTERS

Global Amlodipine Besylate Tablets Market Research Report 2025

Code: QYRE-Auto-38E9912
Report
July 2025
Pages:80
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Amlodipine Besylate Tablets Market

The global market for Amlodipine Besylate Tablets was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Amlodipine besylate is a dihydropyridine calcium channel antagonist, which can selectively inhibit cell membrane calcium ion channels, act on smooth muscle cells and cardiomyocytes, effectively regulate intracellular calcium levels, and enable normal physiological functions. Maintain, thereby dilate the coronary blood vessels and the blood vessels of the whole body, and lower blood pressure. Clinically, it is generally used to treat hypertensive coronary heart disease and essential hypertension. Amlodipine can be used alone or in combination with other antihypertensive drugs, chronic stable angina and variant angina.
North American market for Amlodipine Besylate Tablets is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Amlodipine Besylate Tablets is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Amlodipine Besylate Tablets include China Resources Double-Crane Pharmaceutical, Pfizer, North China Pharmaceutical, AstraZeneca, Sanofi, Roche, Bristol-Myers Squibb, Yangtze River Pharmaceutical, Shanghai Shyndec Pharmaceutical, Jingfeng Pharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Amlodipine Besylate Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Amlodipine Besylate Tablets.
The Amlodipine Besylate Tablets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Amlodipine Besylate Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Amlodipine Besylate Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Amlodipine Besylate Tablets Market Report

Report Metric Details
Report Name Amlodipine Besylate Tablets Market
Segment by Type
  • 5 Milligrams
  • 10 Milligrams
Segment by Application
  • Hospital
  • Pharmacy
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company China Resources Double-Crane Pharmaceutical, Pfizer, North China Pharmaceutical, AstraZeneca, Sanofi, Roche, Bristol-Myers Squibb, Yangtze River Pharmaceutical, Shanghai Shyndec Pharmaceutical, Jingfeng Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Amlodipine Besylate Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Amlodipine Besylate Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Amlodipine Besylate Tablets Market report?

Ans: The main players in the Amlodipine Besylate Tablets Market are China Resources Double-Crane Pharmaceutical, Pfizer, North China Pharmaceutical, AstraZeneca, Sanofi, Roche, Bristol-Myers Squibb, Yangtze River Pharmaceutical, Shanghai Shyndec Pharmaceutical, Jingfeng Pharmaceutical

What are the Application segmentation covered in the Amlodipine Besylate Tablets Market report?

Ans: The Applications covered in the Amlodipine Besylate Tablets Market report are Hospital, Pharmacy

What are the Type segmentation covered in the Amlodipine Besylate Tablets Market report?

Ans: The Types covered in the Amlodipine Besylate Tablets Market report are 5 Milligrams, 10 Milligrams

1 Amlodipine Besylate Tablets Market Overview
1.1 Product Definition
1.2 Amlodipine Besylate Tablets by Type
1.2.1 Global Amlodipine Besylate Tablets Market Value Comparison by Type (2024 VS 2031)
1.2.2 5 Milligrams
1.2.3 10 Milligrams
1.3 Amlodipine Besylate Tablets by Application
1.3.1 Global Amlodipine Besylate Tablets Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Global Amlodipine Besylate Tablets Market Size Estimates and Forecasts
1.4.1 Global Amlodipine Besylate Tablets Revenue 2020-2031
1.4.2 Global Amlodipine Besylate Tablets Sales 2020-2031
1.4.3 Global Amlodipine Besylate Tablets Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Amlodipine Besylate Tablets Market Competition by Manufacturers
2.1 Global Amlodipine Besylate Tablets Sales Market Share by Manufacturers (2020-2025)
2.2 Global Amlodipine Besylate Tablets Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Amlodipine Besylate Tablets Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Amlodipine Besylate Tablets, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Amlodipine Besylate Tablets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Amlodipine Besylate Tablets, Product Type & Application
2.7 Global Key Manufacturers of Amlodipine Besylate Tablets, Date of Enter into This Industry
2.8 Global Amlodipine Besylate Tablets Market Competitive Situation and Trends
2.8.1 Global Amlodipine Besylate Tablets Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Amlodipine Besylate Tablets Players Market Share by Revenue
2.8.3 Global Amlodipine Besylate Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Amlodipine Besylate Tablets Market Scenario by Region
3.1 Global Amlodipine Besylate Tablets Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Amlodipine Besylate Tablets Sales by Region: 2020-2031
3.2.1 Global Amlodipine Besylate Tablets Sales by Region: 2020-2025
3.2.2 Global Amlodipine Besylate Tablets Sales by Region: 2026-2031
3.3 Global Amlodipine Besylate Tablets Revenue by Region: 2020-2031
3.3.1 Global Amlodipine Besylate Tablets Revenue by Region: 2020-2025
3.3.2 Global Amlodipine Besylate Tablets Revenue by Region: 2026-2031
3.4 North America Amlodipine Besylate Tablets Market Facts & Figures by Country
3.4.1 North America Amlodipine Besylate Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Amlodipine Besylate Tablets Sales by Country (2020-2031)
3.4.3 North America Amlodipine Besylate Tablets Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Amlodipine Besylate Tablets Market Facts & Figures by Country
3.5.1 Europe Amlodipine Besylate Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Amlodipine Besylate Tablets Sales by Country (2020-2031)
3.5.3 Europe Amlodipine Besylate Tablets Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Amlodipine Besylate Tablets Market Facts & Figures by Region
3.6.1 Asia Pacific Amlodipine Besylate Tablets Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Amlodipine Besylate Tablets Sales by Region (2020-2031)
3.6.3 Asia Pacific Amlodipine Besylate Tablets Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Amlodipine Besylate Tablets Market Facts & Figures by Country
3.7.1 Latin America Amlodipine Besylate Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Amlodipine Besylate Tablets Sales by Country (2020-2031)
3.7.3 Latin America Amlodipine Besylate Tablets Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Amlodipine Besylate Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Amlodipine Besylate Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Amlodipine Besylate Tablets Sales by Country (2020-2031)
3.8.3 Middle East and Africa Amlodipine Besylate Tablets Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Amlodipine Besylate Tablets Sales by Type (2020-2031)
4.1.1 Global Amlodipine Besylate Tablets Sales by Type (2020-2025)
4.1.2 Global Amlodipine Besylate Tablets Sales by Type (2026-2031)
4.1.3 Global Amlodipine Besylate Tablets Sales Market Share by Type (2020-2031)
4.2 Global Amlodipine Besylate Tablets Revenue by Type (2020-2031)
4.2.1 Global Amlodipine Besylate Tablets Revenue by Type (2020-2025)
4.2.2 Global Amlodipine Besylate Tablets Revenue by Type (2026-2031)
4.2.3 Global Amlodipine Besylate Tablets Revenue Market Share by Type (2020-2031)
4.3 Global Amlodipine Besylate Tablets Price by Type (2020-2031)
5 Segment by Application
5.1 Global Amlodipine Besylate Tablets Sales by Application (2020-2031)
5.1.1 Global Amlodipine Besylate Tablets Sales by Application (2020-2025)
5.1.2 Global Amlodipine Besylate Tablets Sales by Application (2026-2031)
5.1.3 Global Amlodipine Besylate Tablets Sales Market Share by Application (2020-2031)
5.2 Global Amlodipine Besylate Tablets Revenue by Application (2020-2031)
5.2.1 Global Amlodipine Besylate Tablets Revenue by Application (2020-2025)
5.2.2 Global Amlodipine Besylate Tablets Revenue by Application (2026-2031)
5.2.3 Global Amlodipine Besylate Tablets Revenue Market Share by Application (2020-2031)
5.3 Global Amlodipine Besylate Tablets Price by Application (2020-2031)
6 Key Companies Profiled
6.1 China Resources Double-Crane Pharmaceutical
6.1.1 China Resources Double-Crane Pharmaceutical Company Information
6.1.2 China Resources Double-Crane Pharmaceutical Description and Business Overview
6.1.3 China Resources Double-Crane Pharmaceutical Amlodipine Besylate Tablets Sales, Revenue and Gross Margin (2020-2025)
6.1.4 China Resources Double-Crane Pharmaceutical Amlodipine Besylate Tablets Product Portfolio
6.1.5 China Resources Double-Crane Pharmaceutical Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Company Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Amlodipine Besylate Tablets Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Pfizer Amlodipine Besylate Tablets Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 North China Pharmaceutical
6.3.1 North China Pharmaceutical Company Information
6.3.2 North China Pharmaceutical Description and Business Overview
6.3.3 North China Pharmaceutical Amlodipine Besylate Tablets Sales, Revenue and Gross Margin (2020-2025)
6.3.4 North China Pharmaceutical Amlodipine Besylate Tablets Product Portfolio
6.3.5 North China Pharmaceutical Recent Developments/Updates
6.4 AstraZeneca
6.4.1 AstraZeneca Company Information
6.4.2 AstraZeneca Description and Business Overview
6.4.3 AstraZeneca Amlodipine Besylate Tablets Sales, Revenue and Gross Margin (2020-2025)
6.4.4 AstraZeneca Amlodipine Besylate Tablets Product Portfolio
6.4.5 AstraZeneca Recent Developments/Updates
6.5 Sanofi
6.5.1 Sanofi Company Information
6.5.2 Sanofi Description and Business Overview
6.5.3 Sanofi Amlodipine Besylate Tablets Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Sanofi Amlodipine Besylate Tablets Product Portfolio
6.5.5 Sanofi Recent Developments/Updates
6.6 Roche
6.6.1 Roche Company Information
6.6.2 Roche Description and Business Overview
6.6.3 Roche Amlodipine Besylate Tablets Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Roche Amlodipine Besylate Tablets Product Portfolio
6.6.5 Roche Recent Developments/Updates
6.7 Bristol-Myers Squibb
6.7.1 Bristol-Myers Squibb Company Information
6.7.2 Bristol-Myers Squibb Description and Business Overview
6.7.3 Bristol-Myers Squibb Amlodipine Besylate Tablets Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Bristol-Myers Squibb Amlodipine Besylate Tablets Product Portfolio
6.7.5 Bristol-Myers Squibb Recent Developments/Updates
6.8 Yangtze River Pharmaceutical
6.8.1 Yangtze River Pharmaceutical Company Information
6.8.2 Yangtze River Pharmaceutical Description and Business Overview
6.8.3 Yangtze River Pharmaceutical Amlodipine Besylate Tablets Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Yangtze River Pharmaceutical Amlodipine Besylate Tablets Product Portfolio
6.8.5 Yangtze River Pharmaceutical Recent Developments/Updates
6.9 Shanghai Shyndec Pharmaceutical
6.9.1 Shanghai Shyndec Pharmaceutical Company Information
6.9.2 Shanghai Shyndec Pharmaceutical Description and Business Overview
6.9.3 Shanghai Shyndec Pharmaceutical Amlodipine Besylate Tablets Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Shanghai Shyndec Pharmaceutical Amlodipine Besylate Tablets Product Portfolio
6.9.5 Shanghai Shyndec Pharmaceutical Recent Developments/Updates
6.10 Jingfeng Pharmaceutical
6.10.1 Jingfeng Pharmaceutical Company Information
6.10.2 Jingfeng Pharmaceutical Description and Business Overview
6.10.3 Jingfeng Pharmaceutical Amlodipine Besylate Tablets Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Jingfeng Pharmaceutical Amlodipine Besylate Tablets Product Portfolio
6.10.5 Jingfeng Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Amlodipine Besylate Tablets Industry Chain Analysis
7.2 Amlodipine Besylate Tablets Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Amlodipine Besylate Tablets Production Mode & Process Analysis
7.4 Amlodipine Besylate Tablets Sales and Marketing
7.4.1 Amlodipine Besylate Tablets Sales Channels
7.4.2 Amlodipine Besylate Tablets Distributors
7.5 Amlodipine Besylate Tablets Customer Analysis
8 Amlodipine Besylate Tablets Market Dynamics
8.1 Amlodipine Besylate Tablets Industry Trends
8.2 Amlodipine Besylate Tablets Market Drivers
8.3 Amlodipine Besylate Tablets Market Challenges
8.4 Amlodipine Besylate Tablets Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Amlodipine Besylate Tablets Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Amlodipine Besylate Tablets Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Amlodipine Besylate Tablets Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Amlodipine Besylate Tablets Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Amlodipine Besylate Tablets Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Amlodipine Besylate Tablets Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Amlodipine Besylate Tablets Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Amlodipine Besylate Tablets Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Amlodipine Besylate Tablets, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Amlodipine Besylate Tablets, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Amlodipine Besylate Tablets, Product Type & Application
 Table 12. Global Key Manufacturers of Amlodipine Besylate Tablets, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Amlodipine Besylate Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amlodipine Besylate Tablets as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Amlodipine Besylate Tablets Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Amlodipine Besylate Tablets Sales by Region (2020-2025) & (K Units)
 Table 18. Global Amlodipine Besylate Tablets Sales Market Share by Region (2020-2025)
 Table 19. Global Amlodipine Besylate Tablets Sales by Region (2026-2031) & (K Units)
 Table 20. Global Amlodipine Besylate Tablets Sales Market Share by Region (2026-2031)
 Table 21. Global Amlodipine Besylate Tablets Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Amlodipine Besylate Tablets Revenue Market Share by Region (2020-2025)
 Table 23. Global Amlodipine Besylate Tablets Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Amlodipine Besylate Tablets Revenue Market Share by Region (2026-2031)
 Table 25. North America Amlodipine Besylate Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Amlodipine Besylate Tablets Sales by Country (2020-2025) & (K Units)
 Table 27. North America Amlodipine Besylate Tablets Sales by Country (2026-2031) & (K Units)
 Table 28. North America Amlodipine Besylate Tablets Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Amlodipine Besylate Tablets Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Amlodipine Besylate Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Amlodipine Besylate Tablets Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Amlodipine Besylate Tablets Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Amlodipine Besylate Tablets Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Amlodipine Besylate Tablets Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Amlodipine Besylate Tablets Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Amlodipine Besylate Tablets Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Amlodipine Besylate Tablets Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Amlodipine Besylate Tablets Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Amlodipine Besylate Tablets Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Amlodipine Besylate Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Amlodipine Besylate Tablets Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Amlodipine Besylate Tablets Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Amlodipine Besylate Tablets Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Amlodipine Besylate Tablets Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Amlodipine Besylate Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Amlodipine Besylate Tablets Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Amlodipine Besylate Tablets Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Amlodipine Besylate Tablets Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Amlodipine Besylate Tablets Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Amlodipine Besylate Tablets Sales (K Units) by Type (2020-2025)
 Table 51. Global Amlodipine Besylate Tablets Sales (K Units) by Type (2026-2031)
 Table 52. Global Amlodipine Besylate Tablets Sales Market Share by Type (2020-2025)
 Table 53. Global Amlodipine Besylate Tablets Sales Market Share by Type (2026-2031)
 Table 54. Global Amlodipine Besylate Tablets Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Amlodipine Besylate Tablets Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Amlodipine Besylate Tablets Revenue Market Share by Type (2020-2025)
 Table 57. Global Amlodipine Besylate Tablets Revenue Market Share by Type (2026-2031)
 Table 58. Global Amlodipine Besylate Tablets Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Amlodipine Besylate Tablets Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Amlodipine Besylate Tablets Sales (K Units) by Application (2020-2025)
 Table 61. Global Amlodipine Besylate Tablets Sales (K Units) by Application (2026-2031)
 Table 62. Global Amlodipine Besylate Tablets Sales Market Share by Application (2020-2025)
 Table 63. Global Amlodipine Besylate Tablets Sales Market Share by Application (2026-2031)
 Table 64. Global Amlodipine Besylate Tablets Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Amlodipine Besylate Tablets Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Amlodipine Besylate Tablets Revenue Market Share by Application (2020-2025)
 Table 67. Global Amlodipine Besylate Tablets Revenue Market Share by Application (2026-2031)
 Table 68. Global Amlodipine Besylate Tablets Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Amlodipine Besylate Tablets Price (US$/Unit) by Application (2026-2031)
 Table 70. China Resources Double-Crane Pharmaceutical Company Information
 Table 71. China Resources Double-Crane Pharmaceutical Description and Business Overview
 Table 72. China Resources Double-Crane Pharmaceutical Amlodipine Besylate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. China Resources Double-Crane Pharmaceutical Amlodipine Besylate Tablets Product
 Table 74. China Resources Double-Crane Pharmaceutical Recent Developments/Updates
 Table 75. Pfizer Company Information
 Table 76. Pfizer Description and Business Overview
 Table 77. Pfizer Amlodipine Besylate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Pfizer Amlodipine Besylate Tablets Product
 Table 79. Pfizer Recent Developments/Updates
 Table 80. North China Pharmaceutical Company Information
 Table 81. North China Pharmaceutical Description and Business Overview
 Table 82. North China Pharmaceutical Amlodipine Besylate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. North China Pharmaceutical Amlodipine Besylate Tablets Product
 Table 84. North China Pharmaceutical Recent Developments/Updates
 Table 85. AstraZeneca Company Information
 Table 86. AstraZeneca Description and Business Overview
 Table 87. AstraZeneca Amlodipine Besylate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. AstraZeneca Amlodipine Besylate Tablets Product
 Table 89. AstraZeneca Recent Developments/Updates
 Table 90. Sanofi Company Information
 Table 91. Sanofi Description and Business Overview
 Table 92. Sanofi Amlodipine Besylate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Sanofi Amlodipine Besylate Tablets Product
 Table 94. Sanofi Recent Developments/Updates
 Table 95. Roche Company Information
 Table 96. Roche Description and Business Overview
 Table 97. Roche Amlodipine Besylate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Roche Amlodipine Besylate Tablets Product
 Table 99. Roche Recent Developments/Updates
 Table 100. Bristol-Myers Squibb Company Information
 Table 101. Bristol-Myers Squibb Description and Business Overview
 Table 102. Bristol-Myers Squibb Amlodipine Besylate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Bristol-Myers Squibb Amlodipine Besylate Tablets Product
 Table 104. Bristol-Myers Squibb Recent Developments/Updates
 Table 105. Yangtze River Pharmaceutical Company Information
 Table 106. Yangtze River Pharmaceutical Description and Business Overview
 Table 107. Yangtze River Pharmaceutical Amlodipine Besylate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Yangtze River Pharmaceutical Amlodipine Besylate Tablets Product
 Table 109. Yangtze River Pharmaceutical Recent Developments/Updates
 Table 110. Shanghai Shyndec Pharmaceutical Company Information
 Table 111. Shanghai Shyndec Pharmaceutical Description and Business Overview
 Table 112. Shanghai Shyndec Pharmaceutical Amlodipine Besylate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Shanghai Shyndec Pharmaceutical Amlodipine Besylate Tablets Product
 Table 114. Shanghai Shyndec Pharmaceutical Recent Developments/Updates
 Table 115. Jingfeng Pharmaceutical Company Information
 Table 116. Jingfeng Pharmaceutical Description and Business Overview
 Table 117. Jingfeng Pharmaceutical Amlodipine Besylate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Jingfeng Pharmaceutical Amlodipine Besylate Tablets Product
 Table 119. Jingfeng Pharmaceutical Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Amlodipine Besylate Tablets Distributors List
 Table 123. Amlodipine Besylate Tablets Customers List
 Table 124. Amlodipine Besylate Tablets Market Trends
 Table 125. Amlodipine Besylate Tablets Market Drivers
 Table 126. Amlodipine Besylate Tablets Market Challenges
 Table 127. Amlodipine Besylate Tablets Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Amlodipine Besylate Tablets
 Figure 2. Global Amlodipine Besylate Tablets Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Amlodipine Besylate Tablets Market Share by Type: 2024 & 2031
 Figure 4. 5 Milligrams Product Picture
 Figure 5. 10 Milligrams Product Picture
 Figure 6. Global Amlodipine Besylate Tablets Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Amlodipine Besylate Tablets Market Share by Application: 2024 & 2031
 Figure 8. Hospital
 Figure 9. Pharmacy
 Figure 10. Global Amlodipine Besylate Tablets Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Amlodipine Besylate Tablets Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Amlodipine Besylate Tablets Sales (2020-2031) & (K Units)
 Figure 13. Global Amlodipine Besylate Tablets Average Price (US$/Unit) & (2020-2031)
 Figure 14. Amlodipine Besylate Tablets Report Years Considered
 Figure 15. Amlodipine Besylate Tablets Sales Share by Manufacturers in 2024
 Figure 16. Global Amlodipine Besylate Tablets Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Amlodipine Besylate Tablets Players: Market Share by Revenue in Amlodipine Besylate Tablets in 2024
 Figure 18. Amlodipine Besylate Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Amlodipine Besylate Tablets Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Amlodipine Besylate Tablets Sales Market Share by Country (2020-2031)
 Figure 21. North America Amlodipine Besylate Tablets Revenue Market Share by Country (2020-2031)
 Figure 22. United States Amlodipine Besylate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Amlodipine Besylate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Amlodipine Besylate Tablets Sales Market Share by Country (2020-2031)
 Figure 25. Europe Amlodipine Besylate Tablets Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Amlodipine Besylate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Amlodipine Besylate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Amlodipine Besylate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Amlodipine Besylate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Amlodipine Besylate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Amlodipine Besylate Tablets Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Amlodipine Besylate Tablets Revenue Market Share by Region (2020-2031)
 Figure 33. China Amlodipine Besylate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Amlodipine Besylate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Amlodipine Besylate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Amlodipine Besylate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Amlodipine Besylate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. China Taiwan Amlodipine Besylate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Indonesia Amlodipine Besylate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Thailand Amlodipine Besylate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Malaysia Amlodipine Besylate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Latin America Amlodipine Besylate Tablets Sales Market Share by Country (2020-2031)
 Figure 43. Latin America Amlodipine Besylate Tablets Revenue Market Share by Country (2020-2031)
 Figure 44. Mexico Amlodipine Besylate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Brazil Amlodipine Besylate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Argentina Amlodipine Besylate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa Amlodipine Besylate Tablets Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Amlodipine Besylate Tablets Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey Amlodipine Besylate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Amlodipine Besylate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE Amlodipine Besylate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of Amlodipine Besylate Tablets by Type (2020-2031)
 Figure 53. Global Revenue Market Share of Amlodipine Besylate Tablets by Type (2020-2031)
 Figure 54. Global Amlodipine Besylate Tablets Price (US$/Unit) by Type (2020-2031)
 Figure 55. Global Sales Market Share of Amlodipine Besylate Tablets by Application (2020-2031)
 Figure 56. Global Revenue Market Share of Amlodipine Besylate Tablets by Application (2020-2031)
 Figure 57. Global Amlodipine Besylate Tablets Price (US$/Unit) by Application (2020-2031)
 Figure 58. Amlodipine Besylate Tablets Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure